Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 81.60
-1.40 (-1.69%)
Sep 8, 2026, 12:01 PM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 13.08 billion as of September 4, 2026. Its market cap has increased by 0.28% in one year.
Market Cap
13.08B
Enterprise Value
12.20B
Revenue
471.13M
Ranking
n/a
PE Ratio
581.25
Stock Price
81.60
ChartMarket Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 13.08B, an increase of 77.88%. That is a compound annual growth rate of 5.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 13.08B | 2.98% |
| Dec 31, 2025 | 12.70B | 5.86% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 23.85B |
| TTY Biopharm Company | 19.15B |
| Handa Pharmaceuticals | 17.47B |
| Synmosa Biopharma | 16.08B |
| ScinoPharm Taiwan | 15.10B |
| YungShin Global Holding | 14.94B |
| Grape King Bio | 13.41B |
| Standard Chemical & Pharmaceutical | 10.01B |